Boaz Palterer, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Autoantibodies | 12 | 2024 | 2118 | 1.390 |
Why?
|
| Nocardia | 1 | 2024 | 9 | 0.940 |
Why?
|
| Nocardia Infections | 1 | 2024 | 19 | 0.930 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome, Type 1 | 1 | 2022 | 3 | 0.830 |
Why?
|
| Hyper-IgM Immunodeficiency Syndrome | 1 | 2022 | 8 | 0.830 |
Why?
|
| Cryptosporidium | 1 | 2022 | 41 | 0.800 |
Why?
|
| Leishmaniasis | 1 | 2022 | 66 | 0.800 |
Why?
|
| Cryptosporidiosis | 1 | 2022 | 53 | 0.790 |
Why?
|
| Myositis | 4 | 2022 | 269 | 0.770 |
Why?
|
| Mycobacterium xenopi | 1 | 2020 | 1 | 0.740 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2020 | 3 | 0.740 |
Why?
|
| Agammaglobulinemia | 1 | 2022 | 173 | 0.720 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2024 | 886 | 0.710 |
Why?
|
| Rheumatoid Factor | 3 | 2023 | 185 | 0.620 |
Why?
|
| Dermatomyositis | 2 | 2022 | 256 | 0.620 |
Why?
|
| Glycine-tRNA Ligase | 1 | 2017 | 2 | 0.580 |
Why?
|
| Arthritis, Rheumatoid | 5 | 2023 | 3763 | 0.570 |
Why?
|
| Perforin | 1 | 2017 | 167 | 0.570 |
Why?
|
| Sjogren's Syndrome | 3 | 2023 | 235 | 0.560 |
Why?
|
| Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2017 | 42 | 0.560 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2024 | 226 | 0.550 |
Why?
|
| Autoimmune Diseases | 5 | 2022 | 2250 | 0.540 |
Why?
|
| Pneumonia, Aspiration | 1 | 2017 | 146 | 0.540 |
Why?
|
| Antibodies, Antinuclear | 4 | 2022 | 344 | 0.530 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2023 | 911 | 0.490 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2017 | 264 | 0.450 |
Why?
|
| Isoantibodies | 1 | 2017 | 661 | 0.440 |
Why?
|
| Neuromyelitis Optica | 1 | 2017 | 259 | 0.440 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1791 | 0.440 |
Why?
|
| Muscular Diseases | 1 | 2017 | 551 | 0.410 |
Why?
|
| Connective Tissue Diseases | 2 | 2023 | 286 | 0.350 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2023 | 2159 | 0.330 |
Why?
|
| Immunoglobulin M | 4 | 2023 | 1529 | 0.320 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 1394 | 0.280 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 3 | 2022 | 426 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 3 | 2024 | 801 | 0.260 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2024 | 40 | 0.240 |
Why?
|
| Autoimmunity | 2 | 2024 | 1370 | 0.230 |
Why?
|
| Interleukin-7 | 1 | 2024 | 142 | 0.230 |
Why?
|
| CD40 Ligand | 2 | 2022 | 521 | 0.210 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2023 | 102 | 0.200 |
Why?
|
| Jacobsen Distal 11q Deletion Syndrome | 1 | 2021 | 2 | 0.200 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 1 | 2021 | 23 | 0.200 |
Why?
|
| Glomerulonephritis, Membranous | 1 | 2022 | 88 | 0.190 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 3334 | 0.190 |
Why?
|
| Mastocytosis, Systemic | 1 | 2022 | 102 | 0.190 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2020 | 69 | 0.180 |
Why?
|
| Mastocytosis | 1 | 2022 | 149 | 0.180 |
Why?
|
| Killer Cells, Natural | 3 | 2024 | 2203 | 0.170 |
Why?
|
| Mutation | 3 | 2021 | 29932 | 0.170 |
Why?
|
| Interferon Type I | 1 | 2023 | 559 | 0.170 |
Why?
|
| Immunoassay | 2 | 2022 | 746 | 0.170 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2023 | 557 | 0.170 |
Why?
|
| Chromosomes, Human, X | 1 | 2021 | 321 | 0.170 |
Why?
|
| Immunocompromised Host | 1 | 2023 | 857 | 0.150 |
Why?
|
| Anemia, Megaloblastic | 1 | 2017 | 24 | 0.150 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2019 | 111 | 0.150 |
Why?
|
| Scleroderma, Systemic | 1 | 2021 | 344 | 0.140 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4541 | 0.140 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2019 | 165 | 0.140 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2017 | 60 | 0.140 |
Why?
|
| Immunization, Passive | 1 | 2019 | 616 | 0.140 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2017 | 173 | 0.140 |
Why?
|
| Pulmonary Fibrosis | 1 | 2020 | 506 | 0.140 |
Why?
|
| Humans | 41 | 2024 | 760621 | 0.140 |
Why?
|
| Basophils | 1 | 2018 | 404 | 0.130 |
Why?
|
| Polychondritis, Relapsing | 1 | 2016 | 29 | 0.130 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 639 | 0.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2021 | 727 | 0.130 |
Why?
|
| Valine | 1 | 2017 | 409 | 0.130 |
Why?
|
| Fatal Outcome | 2 | 2017 | 1832 | 0.130 |
Why?
|
| Immunoglobulin A | 3 | 2023 | 979 | 0.130 |
Why?
|
| Chondrocalcinosis | 1 | 2016 | 82 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2023 | 2488 | 0.120 |
Why?
|
| Neck Pain | 1 | 2016 | 186 | 0.120 |
Why?
|
| Alanine | 1 | 2017 | 606 | 0.120 |
Why?
|
| Ulcer | 1 | 2016 | 204 | 0.120 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 2414 | 0.120 |
Why?
|
| Immunoglobulins | 1 | 2017 | 859 | 0.110 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 565 | 0.110 |
Why?
|
| Dermatologic Agents | 1 | 2017 | 307 | 0.110 |
Why?
|
| Cytoplasm | 1 | 2018 | 1516 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2024 | 3707 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 975 | 0.110 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2023 | 158 | 0.110 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2017 | 2471 | 0.100 |
Why?
|
| Dendritic Cells | 2 | 2024 | 2725 | 0.100 |
Why?
|
| Dermatitis, Atopic | 1 | 2019 | 716 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2023 | 3804 | 0.100 |
Why?
|
| Food Hypersensitivity | 1 | 2019 | 697 | 0.100 |
Why?
|
| Lymphocyte Count | 2 | 2024 | 780 | 0.090 |
Why?
|
| Methotrexate | 1 | 2017 | 1719 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 17790 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 916 | 0.090 |
Why?
|
| Asthma | 2 | 2019 | 6172 | 0.090 |
Why?
|
| Sexual Behavior | 1 | 2019 | 2086 | 0.080 |
Why?
|
| Lymphocytes | 1 | 2017 | 2611 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2018 | 1155 | 0.080 |
Why?
|
| Spinal Cord | 1 | 2017 | 1817 | 0.080 |
Why?
|
| Fever | 1 | 2016 | 1617 | 0.080 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 1869 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2145 | 0.070 |
Why?
|
| Lung | 2 | 2023 | 9994 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2024 | 7850 | 0.070 |
Why?
|
| Middle Aged | 8 | 2024 | 220352 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6498 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2017 | 4000 | 0.070 |
Why?
|
| Male | 11 | 2024 | 359744 | 0.060 |
Why?
|
| Heterozygote | 2 | 2023 | 2798 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2024 | 2533 | 0.060 |
Why?
|
| B-Lymphocytes | 3 | 2024 | 4742 | 0.060 |
Why?
|
| Female | 13 | 2024 | 391270 | 0.060 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 50 | 0.060 |
Why?
|
| VDJ Recombinases | 1 | 2024 | 84 | 0.060 |
Why?
|
| NF-kappa B p52 Subunit | 1 | 2023 | 35 | 0.060 |
Why?
|
| Immunocompetence | 1 | 2023 | 138 | 0.060 |
Why?
|
| Langerhans Cells | 1 | 2024 | 171 | 0.060 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2023 | 106 | 0.050 |
Why?
|
| I-kappa B Proteins | 1 | 2023 | 212 | 0.050 |
Why?
|
| Receptors, Phospholipase A2 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Adult | 6 | 2024 | 219994 | 0.050 |
Why?
|
| Antigens, Nuclear | 1 | 2022 | 184 | 0.050 |
Why?
|
| Tryptases | 1 | 2022 | 176 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2024 | 3387 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 329 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2023 | 388 | 0.050 |
Why?
|
| Syndrome | 2 | 2018 | 3280 | 0.050 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2024 | 533 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2021 | 736 | 0.040 |
Why?
|
| Italy | 1 | 2022 | 841 | 0.040 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 238 | 0.040 |
Why?
|
| Latex Hypersensitivity | 1 | 2019 | 14 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 12965 | 0.040 |
Why?
|
| Lymphopenia | 1 | 2021 | 280 | 0.040 |
Why?
|
| Homozygote | 1 | 2024 | 1788 | 0.040 |
Why?
|
| Automation, Laboratory | 1 | 2019 | 103 | 0.040 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2019 | 71 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10756 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2023 | 1247 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23376 | 0.040 |
Why?
|
| Condoms | 1 | 2019 | 315 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2019 | 818 | 0.040 |
Why?
|
| Aged | 5 | 2024 | 169152 | 0.040 |
Why?
|
| Immunoprecipitation | 1 | 2019 | 877 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 2018 | 372 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 80372 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 10181 | 0.030 |
Why?
|
| Ligases | 1 | 2018 | 332 | 0.030 |
Why?
|
| Semen | 1 | 2019 | 346 | 0.030 |
Why?
|
| Pedigree | 1 | 2024 | 4578 | 0.030 |
Why?
|
| Mast Cells | 1 | 2022 | 1390 | 0.030 |
Why?
|
| Monocytes | 1 | 2024 | 2575 | 0.030 |
Why?
|
| Saliva | 1 | 2019 | 820 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2024 | 2050 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 2019 | 427 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2018 | 1649 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2024 | 2912 | 0.030 |
Why?
|
| Autoantigens | 1 | 2018 | 877 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22072 | 0.030 |
Why?
|
| Alleles | 1 | 2024 | 6898 | 0.030 |
Why?
|
| Mothers | 1 | 2023 | 2186 | 0.030 |
Why?
|
| Arthritis | 1 | 2018 | 666 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 2018 | 1484 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2021 | 2618 | 0.020 |
Why?
|
| Internal Medicine | 1 | 2019 | 1048 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 2536 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 58995 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2021 | 5870 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2019 | 2208 | 0.020 |
Why?
|
| Biopsy | 1 | 2022 | 6771 | 0.020 |
Why?
|
| Mice | 3 | 2024 | 81208 | 0.020 |
Why?
|
| Skin | 1 | 2024 | 4466 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5201 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 74359 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 36290 | 0.020 |
Why?
|
| Child | 3 | 2023 | 79806 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2024 | 5791 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4353 | 0.020 |
Why?
|
| Infant | 2 | 2020 | 36060 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2514 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2024 | 9585 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2024 | 11481 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14372 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 22023 | 0.020 |
Why?
|
| Pneumonia, Viral | 1 | 2023 | 3205 | 0.020 |
Why?
|
| Acute Disease | 1 | 2016 | 7269 | 0.020 |
Why?
|
| Animals | 3 | 2024 | 167963 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2018 | 41335 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22053 | 0.010 |
Why?
|
| Young Adult | 2 | 2021 | 58741 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15289 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2018 | 18957 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16546 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 20080 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29658 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2021 | 42063 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 13308 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 39261 | 0.010 |
Why?
|
| Adolescent | 1 | 2021 | 87810 | 0.010 |
Why?
|